The Infection Control Today® prevention page contains news and information on the latest updates on all facets of infection prevention. From vaccinations and immunizations to controlling air and water flow in a health care system, preventing infections falls not only on the infection prevention staff, but on all who interact within the hospital, from environmental services teams to those planning and building new construction.
May 8th 2024
Learn the basics of the critical role of proper disinfection and sterilization in health care settings, addressing key considerations, best practices, challenges, and future trends.
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Hot Topics in IPC: Influenza, COVID-19, and Mechanical Ventilation and Drug-Resistant Pathogens
November 3rd 2023In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.
Qnovia Collaborates With UVA to Develop Novel Inhaled Therapies for Lung Infections
November 1st 2023Pharmaceutical company Qnovia partners with the University of Virginia (UVA) to create inhaled drugs for lung infections, bolstering their development pipeline with assets for pneumonia and biodefense-related pulmonary infections.
CDC Advises on Limited Nirsevimab Supply and RSV Protection Options
October 31st 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Handheld UV-C Technology: A Solution to Combat Health Care-Associated Infections
October 26th 2023A study led by Piyali Chatterjee, PhD, and the Central Texas Veterans Health Care System explores the potential of handheld filtered Far UV-C devices in reducing hospital-acquired infections. Freestyle Partners, LLC, supported this research.
Overcoming Challenges to Eye Device Reprocessing: A 3-Year Study
October 25th 2023A recent American Journal of Infection Control study, led by Katharine Hoffman, MPH, CIC, LSSGB, and Lisa Waldowski, DNP, RN, CIC, applies Lean Six Sigma to improve eye device reprocessing. The research highlights the challenges, emphasizes adherence to manufacturer instructions, and promotes best practices for patient safety.
Pioneering Antibiotics and Fungicides: An Interview With Christopher Reid
October 23rd 2023ICT speaks with Christopher Reid, PhD, a biological and biomedical Sciences professor, delving into his investigations on antibiotics and fungicides and how his team's investigations will "provide an extra tool in a clinician's" toolbox for treating bacterial fungal infections."
Clarifying Eligibility for the CIC Examination: Insights From CBIC Executive Director
October 20th 2023The Executive Director of the Certification Board of Infection Control and Epidemiology (CBIC) addresses the eligibility guidelines for the Certification in Infection Prevention and Control (CIC) examination. While designed for success, these guidelines are not requirements, ensuring inclusivity for candidates from diverse infection prevention backgrounds. The CBIC emphasizes readiness and offers support to prospective CIC candidates.
INFORM and EPOCH Studies Unveil COVID-19's Heavy Toll on Immunocompromised Individuals
October 20th 2023Recent INFORM and EPOCH studies shed light on the significant risk and poor outcomes faced by immunocompromised individuals due to COVID-19, emphasizing the need for tailored prevention strategies.
Leveraging BIM to Enhance Infection Control in Health Care Facility Development
October 17th 2023Building Information Modeling (BIM) plays a pivotal role in designing health care facilities that minimize infection risks, promoting efficient planning, and coordination while reducing construction challenges.
Universal Decolonization Prevents Infection/Hospitalization According to Study's Results
October 16th 2023A study of 28 nursing homes and nearly 29,000 residents reveals that universal decolonization significantly lowered infection-related hospitalizations, offering hope for improved healthcare outcomes.
Examining Vulnerability Factors in Patients With Candida auris in Maryland
October 13th 2023A study in Maryland from June 2019 to December 2021 analyzed 140 Candida auris cases, revealing that patients often resided in disadvantaged neighborhoods with higher crowding, uninsured rates, and racial diversity. ICT speaks to the lead author.
Sulbactam-Durlobactam Combo Outperforms Colistin in Acinetobacter baumannii Infections
October 13th 2023A phase 3 trial presented at IDWeek 2023 shows that sulbactam-durlobactam (SUL-DUR) reduces mortality and improves outcomes in hospital-acquired Acinetobacter baumannii-calcoaceticus complex infections compared to colistin, offering a promising treatment option.
Infection Intel: News From Healthmark, Henry Schein, APIC, and GP PRO
October 12th 2023Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.